Q1 FY27: PAT plunges 88% on consolidated, falls 28% on standalone

Results RestatedRevenue DeclineEbitda Margin CompressionResults View source PDF Explain this filing

HLEGLAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-20.3%Reaction day

₹476.50

prior close

₹379.60

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-20.2% vs market

Industrial Products peers, median of 131sector-0.3%-20.0% vs sector

On the reaction day the stock moved 20.2 pts less than Nifty Microcap 250 and 20.0 pts less than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-20.3-0.2-20.2-0.3-20.0

Next day

-31.8+0.2-32.0-0.5-31.3

-29.6+0.4-29.9-0.5-29.1

-31.2+0.4-31.6-0.6-30.6

-34.0+0.6-34.6-1.7-32.3

-35.8+0.9-36.7-1.3-34.5

-34.4+0.9-35.3-0.8-33.6

15d

-33.7+0.9-34.6-2.4-31.2

-15.1+2.3-17.5+0.0-15.2

-14.8-1.1-13.7-1.2-13.6

—————

UpDownMarket · Nifty Microcap 250Sector · Industrial Products peers, median of 131Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY27 results (quarter ended June 30, 2026): Standalone revenue fell 8.1% YoY to Rs 150.88 crore; standalone PAT dropped 28% to Rs 11.08 crore (EPS Rs 1.60 vs Rs 2.22). Consolidated revenue grew 5.9% to Rs 300.75 crore, but consolidated PAT plunged 88% to Rs 2.05 crore (EPS Rs 0.40 vs Rs 2.36) due to higher employee and other costs. Comparatives restated for Kinam Enterprise amalgamation. Board also cleared 35th AGM notice.

Likely market impact

Sharp consolidated profit drop on rising costs despite revenue growth will worry investors. Standalone also soft. Restated figures limit comparability.